Who's Afraid Of Big Pharma? Perhaps The Rare Disease Community
This article was originally published in The Pink Sheet Daily
Executive Summary
Concerns are growing that large companies entering the rare disease space will "ruin the market" and decrease the number of orphan product approvals.